Bank China Construction Bank Indonesia Tbk. vs Merck Tbk. — how do they compare? Bank China Construction Bank Indonesia Tbk. trades at Rp68 (market cap 2.55T, 485.4K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Bank China Construction Bank Indonesia Tbk. is the larger of the two by market cap, and Bank China Construction Bank Indonesia Tbk. is more actively traded (485.4K versus 37.6K). Which is the better fit depends on your goals.
| MCOR | MERK | |
|---|---|---|
Market Cap | 2.55T | 1.7T |
Volume | 485.4K | 37.6K |
Lot | 4.85K | 376 |
Turnover | 32.56M | 144.47M |
Average Price | 67.07 | 3,842.23 |
Value | 32.56M | 144.47M |
Indicative Equilibrium Price | 68 | 3,840 |
Indicative Equilibrium Volume | 2 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Multicor (Bank) was established under its original name of PT Multinational Finance Corporation base on notarial deed No.4 of Mr Bagijo, S.H, dated on Apr 2, 1974. The Company’s articles of association has been amended several times, most recently by notarial deed No. 143 of Eliwati Tjitra, S.H., dated Mar 21, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering. The Bank's name was changed to PT Bank Windu Kentjana International Tbk.
Read more on MCOR →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →